Comparing the averaged RM2-PET SUVmean of tumor (3.6 ± 1.5 g/ml) and non-tumor regions (2.0 ± 0.5 g/ml) shows a lower variability in RM2-PET than in PSMA-PET (Fig. 2). This evidence concerns the gene FOLH1 and neoplasm.